Eslamshahr

Researchers are evaluating the effectiveness of two psychological treatments, the Attempted Suicide Short Intervention Program (ASSIP) and Acceptance and Commitment Therapy (ACT), in reducing suicidal thoughts and mental pain. This randomized controlled trial involves adults who have recently attempted suicide, aiming to find which approach better helps reduce these issues. Both therapies have shown promise internationally, but their effectiveness has not been compared in Iran before. The study will enroll 60 participants who are randomly assigned to one of three groups: ASSIP plus treatment as usual (TAU), ACT plus TAU, or TAU alone as a control. ASSIP involves three to four face-to-face sessions lasting 60 to 90 minutes each, while ACT includes four to five individual sessions of about 60 minutes each, based on the "ACT for Life" protocol. TAU may include standard outpatient or inpatient services or pharmacotherapy, without a structured intervention. Participants will be assessed before treatment, immediately after, and at one month follow-up using tools measuring suicidal ideation and mental pain, specifically the Beck Scale for Suicide Ideation and the Orbach & Mikulincer Mental Pain Scale. The study will take place in an outpatient health center, with data analyzed to compare the treatments' impact on reducing suicidal thoughts and psychological pain. The results aim to inform mental health practices and suicide prevention strategies in Iran and similar settings.